Canadian Psychiatric Association

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)

Guest Editorial
Eating Disorders
Paul E. Garfinkel
PDF

In Review
Pharmacologic Treatment of Eating Disorders
April J Zhu, B Timothy Walsh
PDF

Psychological Treatments for Anorexia Nervosa: A Review of Published Studies and Promising New Directions
Allan S Kaplan

PDF

Original Research
Acute Psychiatric Inpatient Care for People With a Dual Diagnosis: Patient Profiles and Lengths of Stay

Philip Burge, Hélène Ouellette-Kuntz, Haider Saeed, Bruce McCreary, Dana Paquette, Franklin Sim

PDF

Canadian Geriatric Psychiatrists: Why Do They Do It? A Delphi Study
Susan Lieff, Diana Clarke

PDF

Relation of Blood Counts During Clozapine Treatment to Serum Concentrations of Clozapine and Nor-Clozapine
L Kola Oyewumi, Zack Z Cernovsky, David J Freeman, David L Streiner

PDF

Research Methods in Psychiatry
Breaking Up is Hard to Do: The Heartbreak of Dichotomizing Continuous Data
David L Streiner

PDF

Brief Communciation
Treatment Resistance in Anorexia Nervosa and the Pervasiveness of Ethics in Clinical Decision making
Chris MacDonald

PDF

Topiramate Use in Obese Patients With Binge Eating Disorder: An Open Study
Jose C Appolinario, Leonardo F Fontenelle, Marcelo Papelbaum, Joao R Bueno, Walmir Coutinho

PDF


Book Reviews

The Depressed Child and Adolescent. 2nd ed.

Clinical Assessment of Dangerousness: Empirical Contributions

The Feeling of What Happens: Body and Emotion in the Making of Consciousness

The Evolution of Psychoanalysis: Contemporary Theory and Practice

Psychiatrie gériatrique: esquisse d'une histoire médicale par l'élaboration de son langage

Démystifier les maladies mentales: les troubles de l'enfance et de l'adolescence


Books Received


Letters to the Editor

RE: Who Develops Severe or Fatal Adverse Drug Reactions to Selective Serotonin Reuptake Inhibitors?

RE: Canadian and American Psychiatrists' Attitudes Toward Dissociative Disorder Diagnoses

Acute Onset of Schizophrenia Following Autocastration

The World Trade Center Disaster

Selenium, Thyroid Hormones, Mood, and Behaviour

Brief Communication

Treatment Resistance in Anorexia Nervosa and the Pervasiveness of Ethics in Clinical Decision making

Chris MacDonald, PhD1

 

Clinical efforts to treat anorexia nervosa (AN) are constantly resisted by patients. Although the primacy of patient autonomy is a cornerstone of modern medical ethics, clinicians will nonetheless often be justified in pursuing particular interventions despite such resistance, given the reduced competency of patients suffering from this multifactorial psychiatric illness. While a literature exists on the ethical justification for imposing treatment, that literature has focused exclusively on situations in which patients refuse treatment outright. When patients resist rather than refuse treatment, clinicians are faced with the ethical challenge of deciding whether particular interventions constitute justified infringements upon patient autonomy. Given the fact that treatment resistance is endemic to AN, we see that ethical decision making must also be a continual part of the disorder’s treatment. This paper argues that the treatment of AN merely constitutes a particularly clear example of what is in fact a general phenomenon: ethical decision making pervades all clinical practice.

(Can J Psychiatry 2002;47:267–270)

Clinical Implications

  • Clinicians should be particularly careful about infringing upon the already-limited autonomy of patients with anorexia nervosa (AN).
  • Ethical issues are pervasive in clinical settings, and even daily, nonemergent ethical issues deserve our careful ethical consideration.
  • Psychiatric practice provides fertile territory for examining ethical challenges faced in all clinical settings.

Limitations

  • The considerations presented here are preliminary; the ethics of dealing with treatment resistance has received insufficient attention in the bioethics and eating disorder literature.
  • More critical attention needs to be focused on the less obvious ways in which patient autonomy is limited in clinical settings.
  • This discussion draws upon the literature on eating disorders and bioethics. Its scope could be broadened through an examination of treatment resistance in other psychiatric illnesses.

Key Words: ethics, treatment resistance, patient autonomy, eating disorders, clinical decision making

Résumé: La résistance au traitement dans l’anorexie mentale et l’omniprésence de l’éthique dans la prise de décisions cliniques


Anorexia nervosa (AN) is a multifactorial psychiatric disorder (Note 1) characterized by significantly diminished body weight and distorted body image that is often accompanied by denial and general cognitive impairment. More than 90% of cases occur in girls and women, and it is thought to affect 0.5% to 1.0% of females in late adolescence and early adulthood (1). Long-term mortality for AN is over 10%, with death most often resulting from starvation, suicide, or electrolyte imbalance (1).

Treatment programs for AN generally combine nutritional therapy aimed at increasing body weight and restoring electrolyte levels with psychiatric therapy or family therapy, or both, aimed at remedying underlying sources of the problem (which are still not well understood). Patients suffering from AN, however, do not want to gain weight. Indeed, they typically manifest an intense fear of weight gain, even when they are bordering on physical collapse from malnutrition. They thus typically resist treatment, in one way or another. Such resistance may manifest itself in several ways. These include, but certainly are not limited to, refusal to eat the medically prescribed quantity of food, removal of nasogastric (NG) tubes, and covert exercise or consumption of laxatives or emetics in an attempt to counter the effects of therapeutic nutrition. This sort of behaviour and the fact that a high percentage of patients continue to be treatment-refractory contribute to the perception that AN patients are difficult. (2).

Little attention has been given to the ethical aspects of dealing with treatment resistance in the clinical management of AN. What little attention has been given to the ethics of treating this illness has focused largely on the issue of treatment refusal, rather than treatment resistance. That is, attention has focused on the question of what circumstances may justify clinicians’ forcing treatment upon a patient who categorically refuses to cooperate (3–8). Treatment refusal only leads to a genuine dilemma when the patient’s physical condition has deteriorated to the point where her life is in grave danger. The dilemma in such cases is typically whether to respect the patient’s autonomy or to impose tube-feeding aided by physical and pharmacologic restraints. Such cases are indeed tragic and worthy of ethical analysis. But such cases are also quite rare. Treatment resistance, on the other hand, is quite common. Such being the case, it seems clear that the ethics of dealing with treatment resistance warrants increased discussion.

 

Faced with a patient who resists treatment, clinicians may find themselves engaging in various forms of coercion, persuasion, and manipulation. Some of these practices will be subtle, and others will be overt. Even voluntary patients will have their actions limited or modified in a range of ways. For example, even when in hospital voluntarily, patients still have their lives controlled to a remarkable degree by the health care professionals responsible for their care. Among the practices in which clinicians might engage are the following:

  • restricting the patient’s movement within the hospital (for example, ordering her to stay in her room or on the ward)
  • threatening outpatients with hospitalization
  • demanding that an inpatient eat 100% of her meal
  • cajoling the patient into doing volunteer work, with the hope that forging such social connections will benefit the patient
  • forbidding patients to exercise (as opposed to merely prescribing bedrest)

Consider, for example, the ethical issues faced by clinicians in the following 2 fictionalized cases.


Case 1

Debbie is an 18-year-old woman suffering from severe, chronic AN. She has been in and out of hospital over the last 4 years. At 164 cm, she weighs just 33 kg. Debbie is in the hospital voluntarily. She asserts that the goal of this admission is merely to stabilize her electrolytes and steadfastly refuses any suggestion that she should try to gain weight while in hospital. Debbie has very reluctantly accepted feeding via an NG tube. Any weight gains she might make, however, are offset by her constant pacing in the hallways of the ward. As a result, the attending physician has prescribed total bedrest. Debbie says she gets lonely in her room, however, and is often seen walking up and down the halls, chatting with other patients. When challenged, she returns to her room, only to emerge again as soon as the nurse’s back is turned.